Targeting ROR1 identifies new treatment strategies in hematological cancers.
Biochem Soc Trans. 2017 Apr 15;45(2):457-464. doi: 10.1042/BST20160272.
Biochem Soc Trans. 2017.
PMID: 28408486
Review.